Clinical trial
Combination Therapy in Patients With Depression
NCT00485862 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00485862 |
|---|---|
| Title | Combination Therapy in Patients With Depression |
| Official title | Noradrenergic Augmentation of SSRI Therapy in Patients With Depression Unresponsive or Incompletely Responsive to SSRI Monotherapy |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Depressive Symptoms |
| Intervention type | Drug |
| Interventions | Atomoxetine Hydrochloride, Sertraline, Placebo |
| Enrollment | 214 |
| Start date | Jun 1, 2003 |
| Completion | Jan 1, 2005 |
| First posted | Jun 13, 2007 |
| Last update posted | Jun 13, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: